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Abstract
Background: Exercise-associated hyponatremia (EAH), rhabdomyolysis and renal failure appear to be a unique
problem in ultra-endurance racers.
Methods: We investigated the combined occurrence of EAH and rhabdomyolysis in seven different ultra-endurance
races and disciplines (i.e. multi-stage mountain biking, 24-h mountain biking, 24-h ultra-running and 100-km
ultra-running).
Results: Two (15.4 %) ultra-runners (man and woman) from hyponatremic ultra-athletes (n = 13) and four (4 %)
ultra-runners (four men) from the normonatremic group (n = 100) showed rhabdomyolysis following elevated
blood creatine kinase (CK) levels > 10,000 U/L without the development of renal failure and the necessity of a
medical treatment. Post-race creatine kinase, plasma and urine creatinine significantly increased, while plasma
[Na+] and creatine clearance decreased in hyponatremic and normonatremic athletes, respectively. The percentage
increase of CK was higher in the hyponatremic compared to the normonatremic group (P < 0.05). Post-race CK levels
were higher in ultra-runners compared to mountain bikers (P < 0.01), in faster normonatremic (P < 0.05) and older and
more experienced hyponatremic ultra-athletes (P < 0.05). In all finishers, pre-race plasma [K+] was related to post-race
CK (P < 0.05).
Conclusions: Hyponatremic ultra-athletes tended to develop exercise-induced rhabdomyolysis more frequently than
normonatremic ultra-athletes. Ultra-runners tended to develop rhabdomyolysis more frequently than mountain bikers.
We found no association between post-race plasma [Na+] and CK concentration in both hypo- and normonatremic
ultra-athletes.
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Introduction
Exertional rhabdomyolysis, muscle cell breakdown with
release of toxic chemicals into plasma and urine, is
known as a relatively common response to prolonged
strenuous exercise as running [1–21], but less frequently
described for cycling [22–25] and triathlon [13]. Acute
kidney injury is a potential and serious complication of
severe exertional rhabdomyolysis [5, 6, 11, 18, 20, 21, 24,
26–28] and the prognosis is worse if renal failure de-
velops [17–19, 26–29].
Factors proposed for the development of acute renal
failure include dehydration secondary to inadequate fluid
intake and/or diarrhoea or vomiting [11, 18, 20, 27],
rhabdomyolysis [21, 27] and analgesic use [6, 11, 17, 20,
27, 29]. Aggressive drinking can lead to exercise-associated
hyponatremia (EAH) and by a currently unknown
mechanism induce muscle cell damage which is suffi-
cient to cause kidney failure [6, 9, 14, 29]. According to
Noakes [9], any level of overhydration will impair
muscle cell function and will be sufficient to lead to a
significant muscle cell damage. This can facilitate
rhabdomyolysis and myoglobin release, leading to acute
renal failure [6, 17, 30]. On the contrary, exertional
muscle damage produced by eccentric exercise in* Correspondence: beat.knechtle@hispeed.ch†Equal contributors
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healthy individuals can cause creatine kinase elevations
without renal impairment [1, 2, 7, 8, 31].
Previous studies related to a proposed link between
rhabdomyolysis and EAH [3, 6–8, 14–17, 27, 32–36].
The simultaneous presentation of EAH and rhabdo-
myolysis creates a complicated and opposing treatment
paradox with regard to fluid resuscitation [6, 8, 27].
There are two explanations for the development of EAH
and rhabdomyolysis: one causes the other [14, 16, 27,
37] or they occur independently [14]. EAH could pro-
mote rhabdomyolysis through changes in intracellular
[K+] and/or [Ca++] concentrations and reduce the stabil-
ity of the cell membrane, or through direct mechanism
decrease cell membrane stability through extracellular
fluid osmotically drawn into the muscle cell [6, 14, 27,
35]. If the extracellular [Na+] falls during endurance
exercise, the intracellular [Ca++] is impaired and in-
creases of [Ca++] lead to cellular injury, because arginine
vasopressin is not able to restore the [Na+]/[Ca++] bal-
ance [14]. During EAH, intracellular [K+] is depleted
and transferred to the extracellular compartment and
myocytes are injured [14]. EAH leads to cell swelling
due to extracellular hypoosmolality and their reduction
through extrusion of intracellular [K+] induces rhabdo-
myolysis [35]. On the contrary, rhabdomyolysis may
cause EAH by arginine vasopressin secretion and fluid
leakage into injured muscle [14, 27, 32–35]. Siegel [33]
and also Kim et al. [12] confirmed the strong relation-
ship between post-exercise interleukin-6 and creatine
kinase (CK) concentrations for support that rhabdo-
myolysis is a stimulus for EAH via the syndrome of in-
appropriate antidiuretic hormone secretion [33–35].
To prevent and treat rhabdomyolysis, it is necessary to
measure CK levels as the most common marker to
assess skeletal muscle damage [7, 12] which is also
highly correlated to myoglobin [7, 38]. The high CK
concentrations could provide an explanation for the high
incidence of EAH [36]. The peak CK concentration may
be predictive of the development of renal failure [30].
The determination of other muscle enzymes aids less in-
formation for a reliable diagnosis [26].
Whether an association exists for the combination
of EAH and rhabdomyolysis is currently under debate
[6, 27]. Therefore, in the present analysis, we aimed (i)
to identify athletes who developed simultaneously EAH
and rhabdomyolysis. We aimed (ii) to expose possible
biochemical factors in the hyponatremic and the normo-
natremic group to better explore this association.
Methods
Participants
Institutional review board approval was granted for this
study by the local institutional ethics committee. The
data were collected from 2012 to 2013 during individual
ultra-running and ultra-cycling races. Participants were
from the “Czech Championship 24-h mountain bike
race” in Jihlava city from 2012 to 2013, the “Bike Race
Marathon Rohozec 24 h” in Liberec city in 2012, the “Sri
Chinmoy Self-Transcendence Marathon 24-h race” in
Kladno city in 2012, the “Trilogy Mountain Bike Stage
Race” in Teplice nad Metují in 2012 and 2013 and the
100-km running race in Plzen city in 2013, all held in
the Czech Republic.
Race details
The “Czech Championship 24-h mountain bike race”
took place during the second weekend in June 2012 and
2013 at 12:00 on Saturday and finished at 12:00 on
Sunday. The course comprised a 9.5 km single-track
with an elevation of 220 m. The “Bike Race Marathon
Rohozec 24 h” took place on June 9th and finished on
June 10th 2012. The course comprised a 12.6 km track
with an elevation of 250 m. In both races a single aid
station located at the start/finish area was provided by
the organizer with a variety of food and beverages. The
ultra-mountain bikers were allowed to be supported by
additional food and drinks in their pit stops. The “Sri
Chinmoy Self-Transcendence Marathon 24-h race” took
place from July 21st to July 22nd 2012. The lap was 1 km,
situated around an athletic stadium on asphalt with 1 m
change in altitude. The organizer provided the athletes
with a buffet where both warm and cold food and
beverages were offered. The “Trilogy Mountain Bike
Stage Race” took place the first week in July 2012 and
2013. The prologue covered 3 km with 300 m differ-
ence in elevation. The first stage covered 66 km with
2,200 m of altitude to climb, the second stage was
63 km in length with 2,300 m difference in elevation
and the third stage was 78.8 km with 3,593 m. The
“Czech championship 100-km running race” was held
on July 9th 2013 and the ultra-runners had to run 66
times a lap of 1,500 m in length.
Procedures, measurements and calculations
At each race, blood and urine measurements were
provided during registration the day before each race.
Post-race measurements were upon completion of the
race. Blood samples were drawn from the seated athlete
into heparinized tubes via an antecubital vein. One
Sarstedt S-Monovette (plasma gel, 7.5 ml) for chemical
analysis was cooled, sent to the laboratory and analysed
within 6 h. Blood samples were obtained to determine
pre- and post-race plasma [Na+], plasma [K+], plasma
and urine creatinine and plasma CK. Plasma [Na+],
plasma [K+], plasma creatinine and plasma CK were
determined using biochemical analyzer Modular SWA
P300 (Roche, Basel, Switzerland). Samples of urine were
collected in one Sarstedt Monovette for urine (10 ml)
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and sent to the laboratory. CK was determined in urine
samples using biochemical analyzer Modular SWA P300
(Roche, Basel, Switzerland).
Statistical analysis
Race performance was identical with the absolute rank-
ing in each race due to the connection of runners,
mountain bikers and various disciplines (i.e. 24-h race,
stage race, 100-km race). Continuous data underwent
normality test with the D’Agostino and Pearson omnibus
normality test. Because data did not pass normality test-
ing, Spearman correlation analyses were used to examine
the associations between blood and urinary parameters
and pre-race characteristics within the hyponatremic
group and the normonatremic group and all finishers.
Paired sample t-tests or the Wilcoxon signed-rank tests
(within different races and within genders, within all fin-
ishers, the normonatremic and the hyponatremic group)
were used to compare parameters before and after the
race as appropriate and to compare continuous mea-
sures. Mann–Whitney test was used for group compari-
sons (hyponatremic and normonatremic, ultra-runners
and mountain bikers). Variables as post-race CK and
type of race and post-race CK and gender were com-
pared using one-way analysis of variance (ANOVA) and
Tukey’s multiple comparison tests. Statistical signifi-
cance was set at P < 0.05.
Results
Of the 145 ultra-runners and ultra-mountain bikers
included in this study, 113 (81.8 %) finishers underwent
body mass measurements and provided pre and post-
race blood and urine samples. Thirty-two ultra-athletes
did not finish their race or they did not undergo all mea-
surements. Thirteen (11.5 %) finishers developed EAH,
the remaining subjects (n = 100) were normonatremic.
Two (1.8 %) ultra-runners (one man and one woman)
from all finishers (n = 113), that means two (15.4 %)
from the hyponatremic ultra-athletes (n = 13) and four
(3.5 %) from all finishers and four (4 %) ultra-runners
(four men) from the normonatremic group (n = 100)
showed rhabdomyolysis following elevated blood CK
levels > 10,000 U/L without the development of renal
failure and the necessity of a medical treatment. Data of
all cases with rhabdomyolysis (cases 1–6) are presented
in Tables 1 and 2. Pre-race variables, age, race perform-
ance and body mass of present six cases with rhabdo-
myolysis including two ones with simultaneously EAH
and rhabdomyolysis are shown in Table 1. Percentage
changes in their blood and urine parameters (CK, plasma
[Na+], plasma [K+], plasma creatinine, urine creatinine
and creatinine clearance) are shown in Table 2.
We combined the racers by each ultra-endurance dis-
ciplines to four categories (SMTB - mountain bike stage
racers, 24 MTB - 24-h ultra-mountain bikers, 24 RUN -
24-h ultra-runners and 100RUN - 100-km ultra-runners)
(Tables 3, 4, 5 and 6). The limitation was a small number
of racers in some races or in genders due to the field
nature of research and a toughness of such types of
races. We included this fact into our conclusions and
mentioned it in the discussion. Nevertheless, we divided
racers also by genders to smaller groups to obtain a
more accurate characterization of various endurance
disciplines by post- minus pre-race differences in body
mass, plasma [Na+], plasma [K+], plasma creatinine, urine
creatinine and creatinine clearance (Tables 3, 4, 5 and 6).
Post-race CK levels were significantly higher in ultra-
runners (n = 31) compared to mountain bikers (n = 82)
(P <0.05). There was no difference in post-race plasma
[Na+] between ultra-runners and mountain bikers
(P > 0.05). The highest average post-race CK levels
were in 24RUNners (7,033 ± 9,360 U/L), follow by
100RUNners (3,211 ± 4,617 U/L), 24MTBers (1,123 ±
1,077 U/L) and SMTBers (918 ± 818 U/L). In 24RUNners
post-race increase of CK was significantly higher than in
24MTBers (r = 0.40, P < 0.01).
We compared the hyponatremic (n = 13) and the nor-
monatremic (n = 100) group of ultra-athletes. An average
race performance (absolute order in each race) was 38.5 ±
47.7 in the hyponatremic group and 49.5 ± 43.3 in the
normonatremic group without significant difference
between both groups. Race performance correlated
negatively to post-race (r = −0.37, P <0.05) and per-
centage change (r = −0.31, P < 0.05) in CK only in the
Table 1 Age, body mass, training, pre-race experience, and race performance of subjects with rhabdomyolysis including case 1 and
2 (in bold) with EAH and rhabdomyolysis (n = 6)
Case Age (yrs.) Sex Change in
body mass (%)
Race
(discipline)
Absolute
order
Number of finished
ultra-marathons (n)
Years as an active
biker runner) (yrs.)
Training hours
weekly (h)
1 51 M −2.9 100-km RUN 19 4 27 12
2 38 F −2.6 24-km RUN 1 30 13 15
3 35 M −3.4 24-km RUN 2 5 18 10
4 31 M −0.9 24-km RUN 20 7 5 15
5 26 M −4.7 24-km RUN 6 2 3 4
6 48 M −0.2 100-km RUN 2 3 5 11
Chlíbková et al. Journal of the International Society of Sports Nutrition  (2015) 12:29 Page 3 of 12
normonatremic group. An average age of hyponatremic
athletes was 39.5 ± 6.9 years, normonatremic athletes 38.6
± 8.5 years. Age was associated with post-race (r = 0.58,
P < 0.05) and percentage change (r = 0.61, P < 0.05) in CK
in the hyponatremic group. The number of years as an
active runner (biker) was related to the percentage change
(r = 0.75, P < 0.05) in CK only in the hyponatremic group.
Neither the number of finished ultra-marathons nor the
total number of hours spent by training weekly, nor gen-
der was related to post-race CK concentration (P > 0.05)
in both groups. In the hyponatremic group, CK increased
by 3,456 ± 4,982 U/L and 1.9 ± 2.9 %, respectively, from
baseline (P < 0.01). In the normonatremic group CK in-
creased by 1,831 ± 4,073 U/L and 1.1 ± 2.8 %, respectively,
from baseline (P < 0.01). The percentage increase of CK
was higher in the hyponatremic group (P < 0.05) (Fig. 1).
Post-race CK was related to pre-race plasma [K+] in all
finishers (P < 0.05) (Fig. 2). On the contrary, post-race or
percentage change in CK was not associated with percent-
age change in body mass, post-race plasma [Na+], plasma
[K+], plasma and urine creatinine and creatine clearance
in all finishers, hyponatremic or normonatremic ultra-
athletes (P > 0.05).
In the hyponatremic group, post-race plasma [Na+]
decreased by 5.8 ± 2.1 mmol/L (4.1 ± 1.5 %) (P < 0.01). In
the normonatremic group, post-race plasma [Na+] de-
creased by 1.2 ± 2.4 mmol/L, (0.8 ± 1.7 %) (P < 0.01).
Percentage change in plasma [Na+] was significantly
higher in hyponatremic ultra-athletes (P < 0.05). Plasma
[K+] remained stable post-race (P > 0.05) in hyponatre-
mic ultra-athletes. Post-race plasma [K+] decreased by
5.1 ± 0.9 mmol/L post-race, (1.3 ± 25.3 %) (P < 0.05) in
Table 2 Blood and urine parameters subjects with rhabdomyolysis including case 1 and 2 (in bold) with EAH with rhabdomyolysis
(n = 6)
Case PreR blood
[Na+] (mmol/L)
PostR blood
[Na+] (mmol/L)
Blood [Na+]
change (%)
Blood [K+]
change (%)
PreR blood
CK U/L
PostR blood
CK U/L
Blood CK
change (%)
Blood CR
change (%)
CRCL
change (%)
Urine CR
change (%)
1 138 134 −2.9 23.5 509.4 14512.9 2749.0 25.0 −22.4 102.5
2 137 133 −2.9 −29.2 130.0 15172.9 11571.5 14.3 −14.7 165.6
3 140 138 −1.4 −25.8 112.9 29702.9 26209.0 11.1 −13.0 143.6
4 138 138 0.0 −40.7 150.6 12786.2 8378.2 10.0 −9.9 212.7
5 141 135 −4.3 −15.3 654.1 18085.9 2665.0 33.3 −28.5 165.0
6 137 141 2.9 36.7 321.9 20280.6 6381.5 50.0 −33.4 485.3
Note: PreR = pre-race, PostR = post-race, [Na+] = plasma sodium, [K+] = plasma potassium, CK = creatine kinase, CR = creatinine, CRCL = creatinine clearance
Table 3 Age, anthropometric, blood and urine characteristics of the stage MTBers (n = 32)
Pre-race Post- race Change in absolute Change in percent P-value
Male multi-stage MTBers (n = 28)
Age (yrs.) 36.7 ± 6.2
Body mass (kg) 76.6 ± 6.6 75.8 ± 6.3 −0.7 ± 1.5* −0.9 ± 2.0* <0.05
Plasma sodium (mmol/L) 142.8 ± 1.9 140.0 ± 2.7 −2.8 ± 2.3** −1.9 ± 1.6** <0.01
Plasma potassium(mmol/L) 4.4 ± 0.7 5.2 ± 0.5 0.8 ± 0.9** 21.3 ± 21.7** <0.01
Plasma creatinine (mg/dL) 0.9 ± 0.1 1.2 ± 0.5 0.3 ± 0.5* 33.3 ± 64.8* =0.01
Plasma creatine kinase (U/L) 180.7 ± 95.9 1009.4 ± 812.6 828.7 ± 821.2** 586.8 ± 686.9** <0.01
Plasma creatine clearance (ml/min) 10849.4 ± 1502.9 8953.6 ± 2447.9 −1895.8 ± 2158.7** −17.4 ± 19.3** <0.01
Urine creatinine (mmol/L) 7.2 ± 3.9 19.7 ± 17.6 12.5 ± 17.5** 245.8 ± 284.7** <0.01
Female multi-stage MTBers (n = 4)
Age (yrs.) 39.0 ± 7.2
Body mass (kg) 65.5 ± 2.8 63.2 ± 2.8 −2.3 ± 1.1* −3.5 ± 1.6* <0.05
Plasma sodium (mmol/L) 141.5 ± 2.4 138.8 ± 1.7 −2.8 ± 2.2 −1.9 ± 1.6 0.09
Plasma potassium(mmol/L) 4.7 ± 0.6 4.8 ± 0.4 0.1 ± 0.5 1.8 ± 10.6 0.84
Plasma creatinine (mg/dL) 0.8 ± 0.1 1.0 ± 0.1 0.2 ± 0.1 21.9 ± 15.7 0.68
Plasma creatine kinase (U/L) 118.9 ± 25.4 418.1 ± 413.3 299.2 ± 433.5 308.1 ± 454.3 0.26
Plasma creatine clearance (ml/min) 9862.8 ± 712.2 7943.8 ± 1478.1 −1918.9 ± 1008.3* −19.8 ± 10.8* <0.05
Urine creatinine (mmol/L) 7.2 ± 2.6 17.8 ± 1.0 10.6 ± 2.6** 191.7 ± 159.6** <0.05
Note: Results are presented as mean ± SD; * = P < 0.05, ** = P < 0.01
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Table 4 Age, anthropometric, blood and urine characteristics of the 24-hr MTBers (n = 50)
Pre-race Post- race Change in absolute Change in percent P-value
Male 24-hr MTBers (n = 38)
Age (yrs.) 38.4 ± 9.8
Body mass (kg) 78.8 ± 7.7 77.1 ± 8.0 −1.6 ± 1.5** −2.0 ± 2.1** <0.01
Plasma sodium (mmol/L) 138.0 ± 1.6 137.0 ± 2.6 −1.0 ± 2.8* −0.7 ± 2.0* <0.05
Plasma potassium(mmol/L) 5.5 ± 1.0 5.0 ± 1.1 −0.5 ± 1.3* −7.4 ± 23.2* <0.05
Plasma creatinine (mg/dL) 0.9 ± 0.1 1.2 ± 0.2 0.3 ± 0.2** 32.7 ± 21.8** <0.01
Plasma creatine kinase (U/L) 207.5 ± 92.3 1316.3 ± 1111.9 1108.9 ± 1099.1** 590.9 ± 560.4** <0.01
Plasma creatine clearance (ml/min) 10657.2 ± 1614.2 9623.2 ± 1837.4 −1034.1 ± 1121.0* −9.8 ± 11.7* <0.05
Urine creatinine (mmol/L) 7.9 ± 3.7 18.4 ± 5.7 10.5 ± 6.5** 212.3 ± 236.4** <0.01
Female 24-hr MTBers (n = 12)
Age (yrs.) 37.7 ± 7.4
Body mass (kg) 62.1 ± 5.1 60.0 ± 5.4 −1.9 ± 3.1* −2.7 ± 5.1* <0.05
Plasma sodium (mmol/L) 137.5 ± 2.5 136.6 ± 2.0 −0.9 ± 3.0 −0.6 ± 2.2 0.31
Plasma potassium(mmol/L) 5.1 ± 0.8 4.7 ± 0.6 −0.5 ± 0.7* −8.2 ± 12.0* <0.05
Plasma creatinine (mg/dL) 0.9 ± 0.1 1.0 ± 0.1 0.1 ± 0.2 13.4 ± 20.0 0.05
Plasma creatine kinase (U/L) 148.7 ± 75.7 568.9 ± 293.4 420.2 ± 285.3** 349.9 ± 343.7** <0.01
Plasma creatine clearance (ml/min) 9365.7 ± 1579.9 8228.8 ± 2228.7 −13.0 ± 17.3 −12.5 ± 15.7 0.05
Urine creatinine (mmol/L) 5.4 ± 2.4 15.7 ± 4.9 10.3 ± 4.4** 252.4 ± 207.8** <0.01
Note: Results are presented as mean ± SD; * = P < 0.05, ** = P < 0.01
Table 5 Age, anthropometric, blood and urine characteristics of the 24-hr ultra-runners (n = 12)
Pre-race Post- race Change in absolute Change in percent P-value
Male 24-hr ultra-runners (n = 8)
Age (yrs.) 37.5 ± 8.1
Body mass (kg) 71.1 ± 5.9 70.0 ± 6.7 −1.1 ± 1.2* −1.6 ± 1.8* <0.05
Plasma sodium (mmol/L) 140.1 ± 1.2 139.1 ± 2.0 −1.0 ± 2.3 −0.7 ± 1.7 0.26
Plasma potassium(mmol/L) 6.7 ± 1.1 5.1 ± 0.6 −1.6 ± 1.3* −21.8 ± 17.4* <0.05
Plasma creatinine (mg/dL) 0.9 ± 0.1 0.9 ± 0.2 0.0 ± 0.1 10.6 ± 12.7 0.06
Plasma creatine kinase (U/L) 224.0 ± 192.0 8813.8 ± 10536.4 8589.8 ± 10500.7* 5782.1 ± 8659.2* <0.05
Plasma creatine clearance (ml/min) 10657.2 ± 1614.2 9623.2 ± 1837.4 −1034.1 ± 1121.0* −9.8 ± 11.7* <0.05
Urine creatinine (mmol/L) 7.5 ± 1.3 17.5 ± 2.6 10.0 ± 2.7** 139.2 ± 47.9** <0.01
Female 24-hr ultra-runners (n = 4)
Age (yrs.) 40.0 ± 7.7
Body mass (kg) 56.9 ± 5.2 56.3 ± 5.1 −0.6 ± 0.6 −1.0 ± 1.2 0.16
Plasma sodium (mmol/L) 139.8 ± 2.6 137.8 ± 3.4 −2.0 ± 3.4 −1.4 ± 2.4 0.32
Plasma potassium(mmol/L) 6.2 ± 0.3 4.6 ± 0.2 −1.7 ± 0.2** −26.4 ± 2.9** <0.01
Plasma creatinine (mg/dL) 0.7 ± 0.1 0.7 ± 0.1 0.01 ± 0.0 9.0 ± 7.3 0.18
Plasma creatine kinase (U/L) 99.0 ± 23.5 5507.1 ± 6600.4 5408.1 ± 6580.2** 4765.0 ± 4806.5** 0.19
Plasma creatine clearance (ml/min) 10353.4 ± 795.3 9547.0 ± 845.9 −806.4 ± 838.7 −7.6 ± 7.9 0.15
Urine creatinine (mmol/L) 4.5 ± 2.1 15.2 ± 0.2 10.7 ± 1.9** 327.8 ± 276.6** <0.01
Note: Results are presented as mean ± SD; * = P < 0.05, ** = P < 0.01
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normonatremic ultra-athletes. Pre-race plasma [K+] was
not related to post-race plasma [K+] in all finishers,
hyponatremic or normonatremic ultra-athletes (P > 0.05).
Post-race plasma creatinine increased by 1.1 ± 0.5 mg/dL
(39.5 ± 71.0 %) (P < 0.05) in hyponatremic finishers.
Post-race plasma creatinine increased by 1.1 ± 0.3 mg/
dL (25.2 ± 34.1 %) (P < 0.01) in normonatremic finishers.
Post-race urine creatinine increased by 7.9 ± 7.0 mmol/L
(216 ± 287 %) (P < 0.01) in the hyponatremic group.
Post-race urine creatinine increased by 9.5 ± 5.7 mmol/L
(229 ± 235 %) (p < 0.01) in the normonatremic group.
Post-race plasma creatine clearance decreased by 2,454
± 2,428 ml/min (21.7 ± 18.4 %) (P < 0.01) in the hypo-
natremic group. Plasma creatine clearance decreased by
1,913 ± 1,815 ml/min (18.0 ± 15.6 %) (P < 0.01) in the
normonatremic group. In comparison of the normo-
natremic and the hyponatremic group percentage
change in plasma [K+], plasma and urine creatinine and
creatine clearance did not differ significantly between
both groups.
Table 6 Age, anthropometric, blood and urine characteristics of the 100-km ultra-runners (n = 19)
Pre-race Post- race Change in absolute Change in percent P-value
Male 100 km ultra-runners (n = 4)
Age (yrs.) 43.9 ± 9.6
Body mass (kg) 67.0 ± 8.5 65.1 ± 7.8 −1.8 ± 1.3** −2.6 ± 1.7** <0.01
Plasma sodium (mmol/L) 139.6 ± 2.2 137.8 ± 2.9 −1.8 ± 3.6 −1.3 ± 2.6 0.09
Plasma potassium(mmol/L) 6.2 ± 1.0 5.6 ± 0.7 −0.6 ± 1.6 −6.2 ± 24.9 0.18
Plasma creatinine (mg/dL) 0.9 ± 0.2 1.1 ± 0.3 0.2 ± 0.3 25.8 ± 48.1 0.05
Plasma creatine kinase (U/L) 227.1 ± 148.9 4357.1 ± 5822.5 4130.0 ± 5742.7* 1925.5 ± 2180.3* <0.05
Plasma creatine clearance (ml/min) 8985.3 ± 2219.0 7327.7 ± 2080.2 −1657.5 ± 2146.8** −16.7 ± 17.9* <0.05
Urine creatinine (mmol/L) 6.6 ± 4.6 18.5 ± 4.1 11.9 ± 5.8** 365.2 ± 332.1** <0.01
Female 100 km ultra-runners (n = 5)
Age (yrs.) 40.6 ± 5.8
Body mass (kg) 59.0 ± 7.7 57.6 ± 6.6 −1.4 ± 1.2 −2.3 ± 1.6 0.05
Plasma sodium (mmol/L) 138.4 ± 2.3 136.0 ± 1:6 −2.4 ± 2.7 −1.7 ± 1.9 0.12
Plasma potassium(mmol/L) 5.2 ± 0.9 5.5 ± 0.9 0.3 ± 0.6 7.3 ± 13.0 0.28
Plasma creatinine (mg/dL) 0.8 ± 0.1 1.0 ± 0.2 0.2 ± 0.1* 25.6 ± 20.6* <0.05
Plasma creatine kinase (U/L) 251.1 ± 187.7 1949.3 ± 1357.3 1698.2 ± 1413.2* 990.7 ± 748.9* 0.06
Plasma creatine clearance (ml/min) 9335.1 ± 1748.4 7463.4 ± 2240.3 −1871.7 ± 1199.4* −20.6 ± 12.9* <0.05
Urine creatinine (mmol/L) 8.2 ± 4.8 19.4 ± 7.4 11.2 ± 6.7* 192.2 ± 153.0* <0.05
Note: Results are presented as mean ± SD; * = P < 0.05, ** = P < 0.01
Fig. 1 The percentage increase of CK and decrease in creatine
clearance were higher in the hyponatremic compare to the
normonatremic group (P < 0.05)
Fig. 2 Pre-race plasma [K+] related to post-race CK in all finishers
(P < 0.05)
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Discussion
The most important result was that two (15.4 %) ultra-
runners from 13 hyponatremic and four (4.0 %) ultra-
runners from 100 normonatremic finishers (5.3 % from
a total number of finishers) developed post-race CK
levels higher than 10,000 U/L without the occurrence of
renal failure and the necessity of a medical treatment.
Pre-race characteristics of cases with rhabdomyolysis
(cases 1–6)
The present case 1 (51-year-old man) and case 2 (38-year-
old woman) with EAH and rhabdomyolysis were among
the faster, but not younger finishers in their races. Female
24RUNner case 2 was even the first according to the abso-
lute order among both genders. The 153-km ultra-runners
with EAH and rhabdomyolysis (three men and one
woman) exhibited an average age of 38 ± 8 years in a study
by Ellis et al. [14]. In a recent study published by Hoffman
et al. [8], a 161-km hyponatremic ultra-runner with
rhabdomyolysis was 53 years old. In the study of Boulter
et al. [17], three (from four with acute renal failure) hypo-
natremic male 89-km ultra-marathoners noted their aver-
age age of 34.0 ± 8.7 years. In the study of Bruso et al. [6],
161-km ultra-runners with EAH and rhabdomyolysis were
men with an average age of 39 ± 7 years and they tended
to be younger and faster than those not developing EAH
with rhabdomyolysis. The present normonatremic male
cases with rhabdomyolysis (cases 3–6) with mean age
35.0 ± 9.4 were among the faster finishers and they were
on average younger compared to the rest of the normona-
tremic athletes. As described by Hoffman et al. [7] in their
study of 161-km finishers of “Western States Endurance
Run” (WSER) with rhabdomyolysis, blood CK concentra-
tions were not related to finish time, age or the number of
prior similar completed races. The comparison of the
present hyponatremic cases (1,2) and normonatremic
cases (3–6) with rhabdomyolysis was impossible due to
the low number of cases. Nevertheless, when we com-
pared all hyponatremic and normonatremic cases, the
present older and more trained (i.e. more years spent by
running/biking) hyponatremic ultra-athletes developed
higher post-race CK concentrations than the younger ones
and the less trained hyponatremic ultra-athletes. More-
over, the present faster normonatremic finishers developed
higher post-race CK concentrations than the slower nor-
monatremic finishers. On the contrary, race experience
(i.e. the number of finished ultra-marathons) or the train-
ing frequency and length (i.e. number of training hours
per week) related to an increased CK neither in hypona-
tremic, nor in normonatremic ultra-athletes. Gender was
not related to CK in the present ultra-athletes. The rare
incidence of women with EAH and rhabdomyolysis prob-
ably reflects the ratio of female to male finishers in similar
ultra-endurance races [6].
Creatine kinase concentrations
Normal CK post-race values are up to ~ 2,000 U/L [9]. In
accordance to Sinert et al. [31], inclusion criteria were an
elevated CK of more than 500 U/L and they reported
exertional rhabdomyolysis with admission CK levels be-
tween 700 U/L and 167,000 U/L. CK levels of roughly
500–1500 U/L [24] or approximately over 2,000 U/L are
used as the criterion for statin myopathy [39, 40] and CK
above 10,000 U/L as diagnosis of rhabdomyolysis [27, 31].
In the present study, CK ≥ 2,000 U/L and associated my-
opathy developed three (23.1 %) hyponatremic (one male
and one female 100RUNners and one male 24MTBer) and
fifteen (15 %) normonatremic (six male 24MTBers, two
male and one female 24RUNners, three male and one
female 100RUNners and two male SMTBers) ultra-
athletes. Overall, eighteen (15.9 %) of all present ultra-
athletes (n = 113) developed exercise-associated myopathy.
Cases 1 and 2 developed biochemical EAH and exercise-
induced rhabdomyolysis with CK levels of 14,512 U/L and
15,172 U/L, respectively. The rest of the hyponatremic
group (n = 11) had CK range from 691 U/L to 3,163 U/L.
In the normonatremic cases 3, 5 and 6 with rhabdomyolysis
post-race CK increased in the range from 12,768 U/L to
20,280 U/L. Aside from cases 1 and 2, normonatremic
cases 3, 5 and 6 exhibited CK concentrations higher than
14,512 U/L, the lower initial post-race value of two cases
with EAH and rhabdomyolysis. The study of the 153-km
ultra-runners with EAH and rhabdomyolysis described CK
levels in the range from 15,636 U/L to more than 100,000
U/L [14]. Rhabdomyolysis in combination with EAH in one
male athlete was presented by Putterman [35] with CK
1,545 U/L which peaked at 10,300 U/L. Boulter et al. [17]
described in three 89-km runners with EAH and rhabdo-
myolysis CK levels in a wide range from 5,718 U/L to
48,934 U/L. Hoffman et al. [16] observed higher blood CK
concentrations among those with EAH than those not de-
veloping EAH at the 2011 WSER. In 161-km ultra-run race
mean CK concentrations were even 54,583 U/L in the
hyponatremic group and 30,335 U/L in the normonatremic
group [16]. Percentage change in CK was significantly
higher in the present hyponatremic compare to normona-
tremic ultra-athletes. Hyponatremic finishers with an aver-
age post-race CK 3,658 ± 5,029 U/L tended to develop
exercise induced rhabdomyolysis more than present nor-
monatremic ultra-athletes with an average post-race CK
2,025 ± 4,094 U/L.
We could not compare validly different kinds of races
and ultra-disciplines due to the small number of partici-
pants in some observed races. Nevertheless, post-race
plasma CK significantly increased in male and female fin-
ishers in all races (SMTB, 24MTB, 24RUN and 100RUN),
except female SMTBers with a non-significant increase.
Notwithstanding, in comparison of all ultra-runners
(n = 31) and all mountain bikers (n = 82) post-race CK
Chlíbková et al. Journal of the International Society of Sports Nutrition  (2015) 12:29 Page 7 of 12
levels were significantly higher in the present ultra-
runners. Despite a dissimilar number of participants in
each race discipline we found the highest post-race CK
levels in the 24RUNners and the 100RUNners with a sig-
nificantly higher increase of post-race CK in 24RUNners
compared to 24MTBers. Moreover, cases 1 and 6 were
from 100RUN and cases 2, 3, 4 and 5 were 24RUNners. In
accordance to Hoffman et al. [8] mild to moderate eleva-
tions of CK are common in long running distance and
exertional rhabdomyolysis is often associated with EAH.
Skenderi et al. [1] assumed that prolonged exercise at even
moderate intensity can induce asymptomatic exertional
rhabdomyolysis. In their study of 246-km ultra-runners
an increase of post-race CK was 43,763 U/L; neverthe-
less, the ultra-runners did not require hospitalisation.
The reasons for an increase in CK could be also the dur-
ation of races and the large eccentric component of
ultra-running races [7, 12]. On the contrary, a low in-
crease of CK of 542 U/L during 24 h after the exercise
appeared after two hours of cycling [25]. The groups of
ultra-runners and MTBers were not equal; nevertheless,
the present ultra-runners tended to develop more fre-
quently exercise-induced rhabdomyolysis than the present
ultra-MTBers.
Normonatremic cases 3 and 6 (1.8 % from the total of
113 ultra-athletes) developed post-race CK concentra-
tion of 20,280 U/L, a level associated with renal failure
[31]. Acute kidney injury is a complication of severe
rhabdomyolysis (CK > 60,000 U/L to 80,000 U/L) and
the prognosis is worse with renal failure [38]. However,
no present finisher developed acute kidney injury or
renal failure or need a medical treatment. In the present
study the post-race CK levels were not as high as in
other studies. However, the average increase was from
2,665 % to 26,209 % in all cases with rhabdomyolysis.
Factors associated with acute renal failure include
rhabdomyolysis with CK concentrations higher than
20,000 U/L or higher than five times the normal value
[31, 38]. However, no defined level exists. Following
Meijer et al. [30], the risk of acute renal injury in
rhabdomyolysis is low at CK levels lower than 15,000 U/L
to 20,000 U/L. Acute renal injury with CK levels at 5,000
U/L usually occurs with hypovolemia (low circulating
volume) or aciduria (acidic urine) [26, 27, 29, 31]. How-
ever, exercise may induces factors protect against hypo-
volemia and aciduria. Exercise-induced rhabdomyolysis
with mean CK concentrations up to 40,000 U/L [1, 31]
has not been reliable to diagnose renal failure [17].
Blood CK concentration was reported from the 161-km
WSER in 1980 through 1983 [3, 4], 1995 [5], 2009 [6] and
2010 [7] and Bruso et al. [6] first defined the relationship
between EAH and rhabdomyolysis in the 161-km ultra-
run in five runners with CK values of 40,000 U/L. CK con-
centrations in the 2010 WSER finishers were higher than
values previously reported [7]. Hoffman et al. [7] sug-
gested that stress caused by trail running race with its
challenging conditions produced severe muscle damage.
However, CK values higher than 20,000 U/L are com-
mon for this type of event and seldom result in detri-
mental consequences. Hoffman et al. [7] found no
athlete with acute renal failure, despite high mean CK
levels of 32,956 U/L. Thirty-nine ultra-runners finishing
a 245-km race with CK values exceeding 40,000 U/L
also had not been shown to have acute renal failure [1].
On the contrary, four cases of acute renal failure in the
Comrades marathon had various levels of CK values of
39,000 U/L, 29, 800 U/L, 24,120 U/L and 2,220 U/L
[17]. In the cohort of twenty-six patients with severe
rhabdomyolysis the average level of CK with 38,351 U/L
was predicted the development of acute renal failure
[30]. Nevertheless, exercise-induced rhabdomyolysis
rarely progresses to acute renal failure [27, 31] and less
severe forms of rhabdomyolysis or in cases of hyperCK-
emia (i.e. chronic or intermittent muscle destruction)
present with no renal failure [26]. Moreover, exertional
muscle damage produced by eccentric exercise can lead
to an elevated CK without renal impairment [2, 39]. CK
level is, therefore, not useful in distinguishing acute
renal failure [2, 31, 41]. Given the wide range of CK
levels the value of CK is limited to diagnose rhabdo-
myolysis [30]. Factors for renal failure in cases of exer-
tional rhabdomyolysis in marathon running could be a
pre-existing viral/bacterial infection, heat stress, dehy-
dration, latent myopathy, NSAID (non-steroidal anti-
inflammatory drugs), other drugs or analgesic use [2,
27, 31]. In the present study we were not able to observe
these factors in ultra-athletes. However, the present re-
sults support hypothesis that the magnitude of elevated
CK do not have exactly and always predict acute renal
failure [2, 31, 38, 39, 41].
Plasma [Na+] and [K+] concentrations
Plasma [Na+] decreased in cases 1 and 2 with rhabdo-
myolysis and EAH and cases 3 and 5 with rhabdomyolysis
within the hyponatremic and the normonatremic group
with a significantly higher increase in the hyponatremic
group. In different kinds of the present races limited by
various numbers of participant’s plasma [Na+] decreased
in all ultra-disciplines. Hyponatremia as the most com-
mon electrolyte disorder associated with ultra-running
and muscle-cell swelling with mechanical stress caused by
running (footrace) may result in skeletal muscle damage,
rhabdomyolysis, or acute renal injury [27]. However, we
found no study about the occurrence of rhabdomyolysis
and EAH in cycling races. Also the present post-race CK
levels were significantly higher in the ultra-runners and no
mountain biker presented EAH with rhabdomyolysis or
just rhabdomyolysis. Blood [Na+] and CK concentrations
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were negatively correlated in 161-km ultra-runners [16].
In all present finishers (n = 113), in hyponatremic and in
normonatremic finishers, CK concentrations were not
associated with plasma [Na+]. In a recent study of
Hoffman and Stuempfle [15] from the WSER in 2011
and 2013, a significant relationship between plasma
[Na+] and CK concentration was also evident, however,
without the difference between the hyponatremic and
the normonatremic group due to wide variability in
creatine kinase concentrations. Similarly, in the study
of Hoffman et al. [7], the relationship between blood
CK and [Na+] did not reach statistical significance.
The recognition of electrolyte abnormalities associated
with rhabdomyolysis and induced acute kidney injury
like hyperkalemia (serum [K+] ≥ 5.5 mmol/L) is import-
ant to remove [K+] from the body [26]. Hyperkalemia
can be classified according to serum [K+] into mild (5.5
- 6.5 mmol/L), moderate (6.5 - 7.5 mmol/L) and severe
(>7.5 mmol/L) hyperkalemia [42]. A metabolic disorder
known to cause EAH and rhabdomyolysis is also hypo-
kalemia, when [K+] depletion due to cell swelling even-
tually induces rhabdomyolysis [35]. None of present
ultra-athletes showed post-race hypokalemia. Present
case 1 developed post-race plasma [K+] 5.2 mmol/L and
case 2 plasma [K+] of 4.6 mmol/L. A study of four ath-
letes with EAH and rhabdomyolysis showed plasma [K+]
in the range from 4.1 mmol/L to 4.9 mmol/L [14]. The
present levels of post-race plasma [K+] were higher than
in the study of Bruso et al. [6] with an average of
4.0 mmol/L (range 3.4 - 4.9 mmol/L) in his 5 cases with
EAH and rhabdomyolysis and higher than in the study
of Boulter et al. [17] with an average of 4.4 mmol/L.
The interesting finding was that the present cases 1 and
2 showed pre-race values of plasma [K+] (6.8 mmol/L and
6.5 mmol/L, respectively) which tended to be higher than
in other hyponatremic ultra-athletes. In the present cases
with just rhabdomyolysis (cases 3–5), post-race plasma [K
+] ranged from 4.8 mmol/L to 5.0 mmol/L, only case 6
reached 6.7 mmol/L (moderate post-race hyperkalemia).
Another finding was the post-race decrease of plasma [K+]
in all cases (1–5), except case 6. The reason could be
probably pre-race mild to severe hyperkalemia in cases
1–5 due to the range of pre-race plasma [K+] from
5.9 mmol/L to 8.1 mmol/L (case 4 with 8.1 mmol/L).
On the contrary, case 6 presented with a pre-race level
of 4.9 mmol/L and therefore probably exhibited post-
race increase of plasma [K+]. The average post-race
plasma [K+] in the present normonatremic finishers was
in the range from 3.8 mmol/L to 8.2 mmol/L and
twenty-seven (27 %) athletes developed levels higher
than 5.5 mmol/L. Their average pre-race plasma [K+]
was 5.4 ± 1.2 mmol/L (range 3.5 mmol/L to 9.2 mmol/L)
with fifteen (15 %) ultra-athletes with pre-race level ≥
5.5 mmol/L. Hyponatremic finishers had an average
post-race plasma [K+] in the range from 4.4 mmol/L to
6.5 mmol/L with four (30.8 %) finishers with a level
higher than 5.5 mmol/L. Even in five (38.5 %) hypo-
natremic finishers pre-race plasma [K+] reached levels
of ≥ 5.5 mmol/L. Post-race plasma [K+] significantly de-
creased in both genders in 24MTBers and 24RUNners
and non-significantly in male 100RUNners despite the
limitation of different number of finishers in each ultra-
endurance discipline.
Another finding was that pre-race plasma [K+] showed
an average value of 6.7 mmol/L and 6.2 mmol/L in male
and female 24RUNners, respectively, 5.5 mmol/L and
6.2 mmol/L in male 24MTBers and male 100RUNners,
respectively. On the contrary, the lowest pre-race level
was 4.4 mmol/L in male SMTBers, 4.7 mmol/L in
female SMTBers, 5.2 mmol/L in female 100RUNners,
and we simultaneously found a significant increase in
post-race plasma [K+]. Overall, despite the genders and
the various numbers of racers in each ultra-disciplines
57.9 % 24RUNners, 42.0 % of 24MTBers, 16.7 % 100RUN-
ners and 6.3 % of SMTBers showed pre-race hyperka-
lemia and 47.4 % 100RUNners, 28.1 % SMTBers, 20 %
24MTBers and 16.7 % 24RUNners developed post-race
hyperkalemia.
A further interesting finding was that we found an
association between pre-race levels of plasma [K+] and
post-race CK levels in the present finishers. The ultra-
athletes with higher pre-race plasma [K+] developed
post-race higher CK levels. It also appears that races
with a higher occurrence of pre-race hyperkalemia
tended to a lower occurrence of hyperkalemia post-race
and conversely. However, there was no significant rela-
tionship between pre-race plasma [K+] and post-race
plasma [K+] considering all present ultra-athletes. The
presence of mild pre-race or post-race hyperkalemia in
some present hyponatremic and normonatremic cases
supports either excessive [K+] ingestion pre-race or dur-
ing the race, ingestion of NSAID, reduced renal excre-
tion or tissue breakdown as in rhabdomyolysis [42].
Notwithstanding, we found no association between post-
race plasma [K+] and CK concentration. We have to take
into account that some results could be also caused by
pseudohyperkalemia from leakage of [K+] from the intra-
cellular space during or after blood sampling in field
conditions [42].
Plasma and urine creatinine concentrations
Muscle injury releases creatine and increases blood
creatinine as one of parameters of myocellular damage
[31, 39]. Biochemical criteria for acute renal injury
mean a blood creatinine concentration more than
2.0 mg/dL and 1.5 times of the estimated baseline [27,
31, 39]. Post-race plasma and urine creatinine signifi-
cantly increased and creatine clearance decreased in all
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cases with rhabdomyolysis (cases 1–6), in the hyponatre-
mic and the normonatremic group and in both genders in
all present different races. Current cases 1 and 2 with
EAH and rhabdomyolysis developed an average post-race
creatinine level of 0.95 mg/dL (1.0 mg/dL and 0.8 mg/dL).
In accordance to the study of Bruso et al. [6], their average
level of post-race blood creatinine in cases with EAH and
rhabdomyolysis was higher than in the present study.
Three cases in the study of Bruso et al. [6] developed
acute renal failure with higher blood creatinine (2.8 mg/dL
to 4.9 mg/dL) than two cases without renal failure
(1.1 mg/dL to 1.2 mg/dL), however, without a difference
in CK concentrations. Cases 3–6 with just rhabdomyolysis
showed an average post-race creatinine level in the range
from 1.0 mg/dL to 1.2 mg/dL. In the study of Hoffman
et al. [38], the range for blood creatinine levels was similar
as in the present cases with rhabdomyolysis in the range
from 1.1 mg/dL to 1.4 mg/dL. The present hyponatremic
group developed post-race creatinine concentration in the
range from 0.8 mg/dL to 2.6 mg/dL and the normonatre-
mic group from 0.7 mg/dL to 3.4 mg/dL; however, without
a significant difference between both groups.
Present creatinine levels above the upper limit of
normal were only found in one hyponatremic male
SMTBer (2.6 mg/dL, plus 271.4 %) and one male nor-
monatremic SMTBer (3.4 mg/dL, plus 240.0 %) from a
total of 113 ultra-athletes. The 42-year old hyponatremic
male SMTBer (post-race plasma [Na+] 134 mmol/L)
developed also high pre- and post-race levels of plasma
[K+] (5.5 and 5.7 mmol/L), minus 3.8 percentage change
in body mass; the highest percentage decrease (minus
74.1 %) of creatine clearance within all finishers; however
with post-race CK just 1,197 U/L. The 26-year old normo-
natremic SMTBer showed plasma [Na+] 140 mmol/L, pre-
and post-race levels of plasma [K+] 3.6 and 4.9 mmol/L,
plus 0.6 % percentage change in body mass, the second
highest percentage decrease (minus 70. 4 %) of creatine
clearance within all finishers; however similarly with
post-race CK only 1,168 U/L. Both current cases pre-
sented post-race without the development of renal fail-
ure and the necessity of a medical treatment. Neumayr
et al. investigated the effect of marathon cycling on
renal function in recreational and professional road
cyclists [22, 23] with no evidence for a significant
skeletal muscle damage and a reduced renal perfusion
responsible for the slight impairment of renal function
after marathon cycling [22]. In a study of the 38 recre-
ational male marathon cyclists the increases in plasma
creatinine were 20 %, the decrease of creatinine clear-
ance was similar 18 % [22]. In 16 professional road
cyclists (525-km race), plasma creatinine rose by 33 %,
the decrease of creatine clearance was 25 % [23]. Two
multi-stage mountain bikers in the present study devel-
oped the highest levels of post-race plasma [K+] and the
lowest concentrations of creatine clearance; however,
both with low post-race CK concentrations. Moreover,
these hyponatremic multi-stage bikers showed a higher
percentage increase in post-race CK levels than normo-
natremic biker. In the study of Hoffman et al. [41], 4 %
of their ultra-runners met the criteria for injury (i.e.
blood creatinine 2.0 times of the estimated baseline)
and 29 % for risk (i.e. blood creatinine 1.5 times of the
estimated baseline) of acute renal injury and those
meeting the injury criteria had higher CK concentra-
tions. Nevertheless, very few runners seek or require
medical treatment for acute renal injury [41]. In all
present SMTBers plasma creatinine rose by 33.3 % ±
64.8 in men and by 21.9 ± 15.7 % in women with minus
17.4 ± 19.3 % change in male creatine clearance and
minus 19.8 ± 10.8 % change in female creatine clearance
and their post-race creatine levels and post-race
percentage changes in CK were the lowest from all
different ultra-disciplines in the present study. These
data confirm that the strains of ultramarathon cycling
regardless these two presented cases did not influence
their renal function. Even though, Khalil et al. [43]
suggested that acute renal failure is defined with serum
creatinine >3-fold from baseline, or > 4 mg/dL with
an acute rise of 0.5 mg/d L or greater. The present
multi-stage mountain bikers fulfilled these conditions;
they did not seek or required medical treatment for
acute renal injury. In the present study, correlations
between post-race CK values and plasma creatinine,
urine creatinine or creatine clearance values were not
found.
Limitations
We have to take into account that the number of
present ultra-athletes in various disciplines and gender
representation was different. Further we did not observe
a urine dipstick for a urine colour, blood and myoglobin.
However, direct measurement of myoglobin is less reli-
able and not clinically useful [44]. Moreover, increased
CK levels are associated with increased blood myoglobin
[7, 38]. Hereafter, a development of rhabdomyolysis can
delay several hours after the occurring of EAH due to
the changes in intracellular [K+] and the restoring of
cellular volume [14]. Peak CK level is about 48 to 96 h
after its presentation [44]. In the marathon cyclists renal
parameters remained elevated during 24 h of recovery
[22, 23]. We had no possibility to observe ultra-athletes
one or more days after the race; otherwise the danger of
rhabdomyolysis could be higher.
Practical applications
The value of CK as a prognostic tool is limited, due to
the wide inter-individual range of CK levels. In situations
where the diagnosis of EAH is uncertain, fluid restriction
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during or after the race is contraindicated in case of
dehydration and rhabdomyolysis with impending acute
kidney injury [8, 27, 29, 41].
Conclusions
The present hyponatremic ultra-athletes tended to
develop exercise-induced rhabdomyolysis more than
normonatremic ultra-athletes. Ultra-runners tended to
develop rhabdomyolysis more than mountain bikers.
The present work does not clarify the mechanism that
might be involved in the suggested link between rhabdo-
myolysis and EAH.
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